10x Genomics, Inc.
TXG
$14.01
-$0.27-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.64% | -6.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.64% | -6.14% | |||
| Cost of Revenue | -4.07% | -8.56% | |||
| Gross Profit | 19.00% | -4.97% | |||
| SG&A Expenses | -18.96% | -4.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.76% | -5.33% | |||
| Operating Income | 90.62% | 2.63% | |||
| Income Before Tax | 210.42% | 30.74% | |||
| Income Tax Expenses | 188.62% | 31.48% | |||
| Earnings from Continuing Operations | 200.52% | 29.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 200.52% | 29.92% | |||
| EBIT | 90.62% | 2.63% | |||
| EBITDA | 108.05% | 1.42% | |||
| EPS Basic | 199.61% | 30.51% | |||
| Normalized Basic EPS | 105.37% | 12.46% | |||
| EPS Diluted | 199.61% | 30.51% | |||
| Normalized Diluted EPS | 105.33% | 12.46% | |||
| Average Basic Shares Outstanding | 0.94% | 0.83% | |||
| Average Diluted Shares Outstanding | 1.55% | 0.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||